CA
RLYB icon

CHI Advisors’s Rallybio RLYB Stock Holding History

CHI Advisors’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.32M Sell
48,842
-19,005
-28% -$823K 0.52% 22
2023
Q2 		$3.07M Sell
67,847
-27,221
-29% -$1.33M 0.93% 18
2023
Q1 		$4.34M Buy
95,068
+4,304
+5% +$222K 1.15% 13
2022
Q4 		$4.77M Buy
90,764
+66,477
+274% +$3.92M 1.27% 11
2022
Q3 		$2.81M Buy
+24,287
New +$2.16M 0.76% 20

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors's RLYB Position: Q3 2023 in Review

CHI Advisors reduced its Rallybio (RLYB) stake by 28% in Q3 2023, selling an estimated $823K and leaving 48,842 shares worth $1.32M. The position accounts for 0.52% of the portfolio, ranked #22.

CHI Advisors first reported a position in RLYB in Q3 2022 and has held it in 5 quarters since. The position peaked at $4.77M in Q4 2022. 58 funds tracked by Wall St. Rank hold RLYB as of Q3 2023.

  • CHI Advisors held 48,842 shares of Rallybio worth $1.32M as of Q3 2023.
  • CHI Advisors sold 19,005 Rallybio shares in Q3 2023, an estimated $823K.
  • Rallybio made up 0.52% of CHI Advisors's portfolio in Q3 2023, its #22 holding.
  • CHI Advisors first reported a position in Rallybio in Q3 2022 and has held it in 5 quarters since.
  • CHI Advisors's Rallybio position peaked at $4.77M in Q4 2022.
  • 58 funds tracked by Wall St. Rank held Rallybio as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.